NGL FINECHEM
Back to Balance Sheet
|
NGL FINECHEM Last 5 Year Secured Loans History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Secured Loans | ₹25 Cr | ₹0.75 Cr | ₹2.07 Cr | ₹3.44 Cr | ₹6.13 Cr |
What is the latest Secured Loans ratio of NGL FINECHEM ?
| Year | Secured Loans |
|---|---|
| Mar2025 | ₹25 Cr |
| Mar2024 | ₹0.75 Cr |
| Mar2023 | ₹2.07 Cr |
| Mar2022 | ₹3.44 Cr |
| Mar2021 | ₹6.13 Cr |
How is Secured Loans of NGL FINECHEM Trending?
| Years | Secured Loans | % Change | |
|---|---|---|---|
| Mar2025 | ₹25 Cr | 3,300.81 | |
| Mar2024 | ₹0.75 Cr | -64.06 | |
| Mar2023 | ₹2.07 Cr | -39.67 | |
| Mar2022 | ₹3.44 Cr | -43.96 | |
| Mar2021 | ₹6.13 Cr | - | |
Compare Secured Loans of peers of NGL FINECHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NGL FINECHEM | ₹1,367.4 Cr | -8.9% | -3.8% | 85.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,825.0 Cr | -1.6% | 5.7% | 7.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,535.0 Cr | -4.2% | -1.4% | 9.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹145,733.0 Cr | -2.8% | 5.7% | 39.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,094.0 Cr | -3.2% | 1.2% | 14.2% | Stock Analytics | |
| CIPLA | ₹103,513.0 Cr | -3.6% | -3.7% | -10.2% | Stock Analytics | |
NGL FINECHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NGL FINECHEM | -8.9% |
-3.8% |
85.2% |
| SENSEX | -2.7% |
-9.1% |
2.6% |
You may also like the below Video Courses